Holdings
Commodore Capital LP
As of Jun 30, 2026, Commodore Capital LP reported 30 positions worth US$1.46B. Largest: Relay Therapeutics, Inc., Enliven Therapeutics, Inc. and Cogent Biosciences, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Relay Therapeutics, Inc. | 12M | US$225M | −5M | Jun 30, 2026 |
| Enliven Therapeutics, Inc. | 3.27M | US$166M | no change | Jun 30, 2026 |
| Cogent Biosciences, Inc. | 3.05M | US$118M | +162K | Jun 30, 2026 |
| Amylyx Pharmaceuticals, Inc. | 5.65M | US$101M | no change | Jun 30, 2026 |
| Definium Therapeutics, Inc. | 2M | US$94.1M | no change | Jun 30, 2026 |
| Spyre Therapeutics, Inc. | 847K | US$75.2M | −1.07M | Jun 30, 2026 |
| Alto Neuroscience, Inc. | 2.72M | US$71.9M | no change | Jun 30, 2026 |
| Tango Therapeutics, Inc. | 2.25M | US$70.3M | new | Jun 30, 2026 |
| Eyepoint, Inc. | 4.6M | US$65.8M | +1.77M | Jun 30, 2026 |
| Tyra Biosciences, Inc. | 1.88M | US$59.9M | −600K | Jun 30, 2026 |